Clinical trial
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic…
NCT00178698 · The University of Texas Health Science Center, Houston, Other · Unknown status
Key facts
| NCT number | NCT00178698 |
|---|---|
| Title | Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors |
| Official title | A Phase II Clinical Trial of Cisplatin + Gemcitabine HCl (GEM) + Low-Dose Metronomic Interferon-a (IFN-a) Combined With Fever-Range Whole-Body Thermal Therapy (FR-WB-TT) in Patients With Metastatic/or Locally Advanced Malignancies (Small-Cell Lung Cancer, Neuroendocrine Cancer, Gastric Cancer) |
| Acronym | FR-WB-TT/che |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroendocrine Cancer, Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Gastric Cancer |
| Intervention type | Drug, Other |
| Interventions | thermochemotherapy, Cisplatin, Gemcitabine, Interferon-a |
| Enrollment | 36 |
| Start date | Jul 1, 2002 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2014 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: